Ticker: LZB

La-Z-Boy

Consumer Consumer Cyclical Furnishings, Fixtures & Appliances
Price 30.32
Reco Sell Potential 24 Risk 75 Updated 2026-09-15

Forecast impact

negative
Target +29.2% target fill 77.4%
Reaction D5 +5.92% · D10 +4.84% market trust
Impact Potential -4 · Risk +3 valid until 2026-09-19

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

La-Z-Boy is a manufacturer and retailer of upholstered furniture, primarily known for its recliners. The company operates through several segments, including upholstery, casegoods, and retail. Its core products encompass a wide range of seating options, including sofas, chairs, and home accessories. Major revenue sources include direct-to-consumer sales through company-owned stores and online channels, as well as wholesale distribution to third-party retailers.

Investment Profile

The investment profile of La-Z-Boy is more aligned with balanced investors, given its moderate growth potential and steady dividend yield. The company demonstrates consistent revenue growth and a reliable dividend, appealing to those seeking both income and capital appreciation. Its relatively low volatility suggests a stable investment environment, suitable for investors with a medium to long-term horizon.

Fundamental metrics (experimental) Updated: 2026-09-11
EPS (TTM) — earnings per share for the last 12 months, $
1.99
Revenue QoQ — quarter-over-quarter revenue growth
-16.6%
EPS surprise
-12.8%
20d volatility
4.0%
Dividend yield
3.1%
last ex-date
2026-09-03
AI recommendation changes
Date Before After Reason
2026-08-20 Buy Sell Weak fundamentals and negative momentum raise significant concerns.
2026-07-17 Hold Buy Strong EPS growth and positive revenue momentum.
2026-07-09 Buy Hold Solid fundamentals, but recent momentum is negative.
Analyst forecasts
Date Analyst Action Target Price Then
2026-08-20 KeyBanc Target Lowered 46 → 40 33.91
News Page 1 of 1
Mercury Systems La-Z-Boy Estee Lauder Lowe's Companies Analog Devices Toll Brothers Keysight Technologies Merck Moderna

Stocks to Watch: Moderna and Merck Surge on Positive Cancer Vaccine Trial Results, While Lowe’s and La-Z-Boy Face Declines

Moderna and Merck's shares surged following positive results from a late-stage trial of their personalized cancer vaccine, while other companies like Keysight Technologies and Estee Lauder reported strong earnings, impacting their stock prices positively. Conversely, Lowe's and La-Z-Boy faced declines due to disappointing forecasts and earnings results.